Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 13, 2026
Approximately 5 minutes
Notification of Medical Devices Placed on the Swiss Market – Swissmedic Procedure
Notification of Medical Devices Placed on the Swiss Market – Swissmedic Procedure
Overview and Legal Basis
Since the revision of the Medical Devices Ordinance (MedDO) effective 26 May 2021, the previous notification procedure for medical devices has been replaced by mandatory registration in the Swiss Product Registration Database. This electronic registration serves as the official notification of devices placed on the Swiss market and is required for all medical devices (including in vitro diagnostics, custom-made, and investigational devices under specific conditions). The process ensures traceability, supports market surveillance, vigilance activities, and compliance verification by Swissmedic. Meldung Medizinprodukten - Swissmedic
Who Must Notify/Register
Registration is mandatory for:
- Manufacturers (Swiss or foreign) placing devices on the Swiss market.
- Authorised Representatives (CH-REP) for non-Swiss manufacturers.
- Importers introducing devices into Switzerland.
Pure exporters without Swiss market placement are exempt. The responsible economic operator must complete registration before the device is made available on the Swiss market.
Registration Content and Requirements
Key data to be submitted includes:
- Device identification (UDI-DI where applicable, or Swiss-specific identifiers).
- Economic operator details (CHRN – Swiss Single Registration Number).
- Conformity assessment documentation (certificates, declarations of conformity).
- Classification, intended purpose, and risk class.
- Labelling and instructions for use (in required Swiss languages).
- Vigilance-related information (if relevant).
For legacy devices (previously placed under old directives), transitional provisions apply with specific deadlines.
Submission Process
- All registrations are submitted exclusively through the Swissmedic e-Business portal.
- Step-by-step workflow: Obtain CHRN → Create/update operator profile → Register device(s) or families → Upload supporting documents.
- Validation rules provide immediate feedback on completeness and format.
- Certain changes (e.g., significant modifications, certificate updates) require amendment notifications.
Consequences of Non-Compliance
Failure to register before market placement renders the device non-compliant. Swissmedic may:
- Prohibit market availability.
- Order withdrawal or recall.
- Impose administrative sanctions or fees.
Prompt registration and updates are essential to avoid enforcement actions.
Additional Support and Resources
Swissmedic provides detailed guidance documents, FAQs, technical specifications, and support contacts for the registration process. The e-Business portal includes a test environment (Playground) for practice submissions. Annual statistics on registered devices are published to enhance transparency.
This registration-as-notification system strengthens Switzerland's medical device regulatory framework, ensuring effective oversight, rapid response to safety issues, and alignment with international standards while maintaining national control. Full instructions, portal access, and related resources are available on the Swissmedic notification page. Meldung Medizinprodukten - Swissmedic
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Swiss Authorised Representative (CH-REP) for Medical Devices – Swissmedic Obligations
Non-Swiss manufacturers must appoint a Swiss Authorised Representative (CH-REP) to place medical devices on the Swiss market, ensuring regulatory compliance, vigilance reporting, technical documentation availability, and liaison with Swissmedic under the revised MedDO requirements.
Approximately 5 minutes
Notification of In Vitro Diagnostic Devices Placed on the Swiss Market – Swissmedic Requirements
Swissmedic mandates registration (serving as notification) of all in vitro diagnostic (IVD) medical devices placed on the Swiss market in the Product Registration Database, requiring submission of UDI data, economic operator details, conformity documentation, and classification information to enable traceability, vigilance, and regulatory oversight under the revised MedDO and IVDR-aligned framework.
Approximately 5 minutes
Notification Procedure for Devitalised Human Tissue Products in Switzerland – Swissmedic Guidance
Swissmedic requires notification of devitalised human tissue products (allografts without viable cells) placed on the Swiss market, classifying them as medical devices under specific MedDO provisions, with mandatory submission of product details, donor screening, processing information, and conformity data to ensure safety, traceability, and regulatory oversight prior to distribution.